Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Cann Group Ltd. ( (AU:CAN) ) is now available.
Cann Group Limited has announced the appointment of Connect National Audit Pty Ltd as its new auditor, following the resignation of William Buck Audit (VIC) Pty Ltd. This change, which is pending ratification at the 2025 Annual General Meeting, was made in line with best corporate governance practices and is believed to be in the best interests of the company and its shareholders.
More about Cann Group Ltd.
Cann Group Limited is a company dedicated to enhancing patients’ lives through the development, production, and supply of innovative cannabis medicines. Based in Melbourne, Australia, the company operates a large-scale cultivation and manufacturing facility in Mildura, Victoria, and offers a variety of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, both locally and internationally. Cann Group also owns Satipharm, known for its patent-protected capsule technology.
YTD Price Performance: 220.0%
Average Trading Volume: 1,516
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $10.27M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.
